Issue 6/2023

miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy (713 — 721)

Tian Gao, Yong-Qing Lin,  Hai-Yan Ye,  Wu-Mei Lin

DOI: 10.4149/neo_2023_230711N362

The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway (722 — 732)

Yongkun Wang, Yingchun Li, Cui Ran, Wenjun Le, Jiaxing Dong, Xujing Wang,  Bo Chen,  Xiaohua Jiang

DOI: 10.4149/neo_2023_230614N310

FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells (733 — 746)

Yanghui Bi, Yanfang Yang, Yong Zhang, Caixia Cheng, Peisen Tang, Heng Xiao, Fajia Yuan, Weiwei Wu,  Bin Yang

DOI: 10.4149/neo_2023_230104N8

Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway (747 — 760)

Jia Yuan, Yue Chang, Yalan Dai, Yutong Chen, Rongbin Yue,  Linjuan Zeng

DOI: 10.4149/neo_2023_230125N41